Frontal fibrosing alopecia: receding hairline cause explained

Frontal fibrosing alopecia (FFA) is being seen more often in clinics as a cause of a steadily receding hairline, especially in postmenopausal women, according to Mayo Clinic and acibademinternational.com. It can also affect eyebrows early on, which is a key clue for diagnosis.

Doctors describe FFA as a scarring process on the scalp, meaning the immune system’s inflammation damages hair follicles and they do not grow back once replaced by scar tissue. Recognising the signs promptly matters because treatment started early may slow or halt further loss.

What happened

Specialists outline a consistent pattern: gradual movement of the frontal hairline backwards, often preceded or accompanied by thinning or loss of the eyebrows. According to Mayo Clinic, the affected skin may look smooth and shiny where follicles have been destroyed, reflecting underlying scarring.

Patients commonly report itch, burning or tenderness at the hairline or eyebrows, signalling active inflammation. Doctors also note colour changes around follicles — red, purple or brown depending on skin tone — that point to ongoing irritation of the follicular openings.

Mayo Clinic explains that diagnosis begins with a close scalp and eyebrow examination and questions about symptoms and medical history. When the picture is unclear or to confirm the scarring process, a small scalp biopsy is often performed and examined under a microscope.

acibademinternational.com adds that clinicians use dermoscopy — a magnified view of scalp and hair — and targeted blood tests to rule out other causes of diffuse shedding. In practice, this helps separate FFA from common non‑scarring conditions that behave differently and are treated in other ways.

Treatment plans are tailored to slow immune‑driven damage. According to Mayo Clinic, topical or injected corticosteroids are used to calm inflammation around follicles, sometimes alongside medicines that modulate the immune response such as hydroxychloroquine, tacrolimus or pimecrolimus.

To support retention in areas at risk, clinicians may add minoxidil to help limit further loss. Prescription anti‑androgen options such as finasteride or dutasteride are also used in selected patients to slow progression, but these are unsafe in pregnancy or when pregnancy is possible.

Some doctors also use antibiotics for their anti‑inflammatory effects on the follicle environment, aiming to reduce perifollicular swelling. Across approaches, the goal is disease control rather than regrowth on scarred skin, and responses vary by individual.

The background

FFA sits within lichen planopilaris, an umbrella for inflammatory scalp diseases that lead to scarring (cicatricial) alopecia. In FFA, immune cells cluster around follicles at the frontotemporal hairline and sometimes at the sides, eventually destroying the follicle’s growth machinery.

The earliest visible change may be eyebrow loss before the hairline shifts, a feature highlighted by Mayo Clinic and acibademinternational.com. In men, the same process can target facial hair, including the beard and sideburns, producing small areas of thinning or loss.

Doctors do not yet have a single confirmed cause. According to Mayo Clinic, genetics, hormonal factors, environmental exposures and immune dysregulation are all suspected contributors, which likely interact in ways that differ from person to person.

Because scarring means permanent loss where follicles are replaced by fibrosis, expectations focus on preventing further recession rather than regrowing hair at sites that have already scarred. This distinguishes FFA from many non‑scarring hair loss conditions that can recover once triggers are removed.

On examination, the scalp may show perifollicular scale or subtle discolouration at the active edge. Dermoscopy can reveal reduced follicle openings and signs of inflammation, helping clinicians separate FFA from pattern hair loss, which shows miniaturisation rather than follicle dropout.

Blood tests are not diagnostic for FFA itself but can exclude other contributors to shedding. acibademinternational.com notes that thyroid function, iron stores and a full blood count are common first checks when hair loss is diffuse or more than one cause is possible.

Differential diagnosis matters because hairline changes occur in several conditions. Traction alopecia from tight styles can recede the hairline but is non‑scarring if caught early; our guide on spotting hair loss caused by tight styles explains warning signs and when to ease tension.

Pattern hair loss can also thin the frontal area but typically preserves the very front edge and shows varying shaft diameters rather than smooth, shiny skin. Our overview of male pattern baldness signs and treatment sets out how clinicians identify miniaturisation.

People often notice extra strands at the hairline and worry about sudden shedding. A refresher on how much hair loss is normal can help frame what counts as expected daily shedding versus a change that merits medical review.

For anyone unsure which type they have, a broad primer on alopecia types, causes and warning signs describes how scarring and non‑scarring conditions differ and why timelines and scalp findings guide the next steps.